Back
SoftBank Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
29
SFTBY
SoftBank Group
Last Price:
24.89
Seasonality Move:
9.74%
Sell
25
AKRO
Akero Therapeutics
Last Price:
20.22
Seasonality Move:
16.15%
Sell
29
SoftBank Group (SFTBY)
is a Sell
Is SoftBank Group a Buy, Sell or Hold?
- The current SoftBank Group [SFTBY] share price is $24.89. The Score for SFTBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SFTBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $20.26. The Score for AKRO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SFTBY Stock Price Chart
What is SoftBank Group's stock price today?
-
The SoftBank Group share price today is $24.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SFTBY is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $20.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
SFTBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.1 | Sell |
Relative Strength Index (14 RSI): | 34.63 | Sell |
Chaikin Money Flow: | 17681 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.21 | Sell |
Relative Strength Index (14 RSI): | 31.81 | Sell |
Chaikin Money Flow: | -465905 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.28 - 24.52) | Sell |
Bollinger Bands (100): | (20 - 26.08) | Sell |
SFTBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.08 | Sell |
20-day SMA: | 27.12 | Sell |
50-day SMA: | 28.39 | Sell |
200-day SMA: | 23.6 | Buy |
8-day EMA: | 25.28 | Sell |
20-day EMA: | 26.58 | Sell |
50-day EMA: | 26.97 | Sell |
200-day EMA: | 24.26 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.06 | Sell |
20-day SMA: | 22.39 | Sell |
50-day SMA: | 24.65 | Sell |
200-day SMA: | 29.08 | Sell |
8-day EMA: | 21.09 | Sell |
20-day EMA: | 22.3 | Sell |
50-day EMA: | 23.39 | Sell |
200-day EMA: | 27.61 | Sell |
SoftBank Group Earnings Growth & SFTBY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
SoftBank Group Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |